News tagged with hematological malignancy
Life work culminates in testing of cancer therapy in humans
A cancer-fighting antibody identified by a researcher working at The University of Queensland and Queensland Institute of Medical Research (QIMR) will today be used to treat the first patient, in a Phase 1 clinical trial.
Mar 24, 2011 |
5 / 5 (2) |
0
Researchers find two units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease ...
Nov 13, 2009 |
4.5 / 5 (2) |
1
Gene shut-down may offer early warning of chronic leukemia
A new study shows that certain genes are turned off early, before clinical signs of the disease appear, in the development of chronic leukemia.
Aug 05, 2009 |
not rated yet |
0
Controversial cancer stem cells offer new direction for treatment (w/ Video)
In a review in Science, a University of Rochester Medical Center researcher sorts out the controversy and promise around a dangerous subtype of cancer cells, known as cancer stem cells, which seem capable of res ...
Jun 25, 2009 |
5 / 5 (1) |
2
Search results for hematological malignancy
Study uncovers mechanism by which melanoma drug accelerates secondary skin cancers
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA's ...
Jan 18, 2012 |
5 / 5 (1) |
0
|
Novel brain tumor vaccine acts like bloodhound to locate cancer cells
A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.
Jan 05, 2012 |
not rated yet |
0
|
Most cancer-related blood clots occur in outpatients
(Medical Xpress) -- In a study of nearly 18,000 cancer patients, University of Rochester Medical Center researchers found that when blood clots develop – a well-known and serious complication of cancer treatment – ...
Dec 13, 2011 |
not rated yet |
0
HIV drug reduces graft-versus-host disease in stem cell transplant patients
An HIV drug that redirects immune cell traffic appears to significantly reduce the dangerous complication graft-versus-host disease (GvHD) in blood cancer patients following allogeneic stem cell transplantation (ASCT), according ...
Dec 13, 2011 |
not rated yet |
1
Novel export-inhibitor shows promise for treating chronic lymphocytic leukemia
An experimental drug that works by blocking the export of key control molecules from the nucleus of cancer cells shows promise as a treatment for chronic lymphocytic leukemia (CLL) and other incurable B-cell malignancies, ...
Dec 12, 2011 |
5 / 5 (2) |
0
Study of two sisters sheds light on lymphoma evolution
When a 41-year-old woman was diagnosed with chronic-phase chronic myeloid leukemia, she received a bone marrow transplant and subsequent leukocyte infusion from her sister. These treatments controlled her leukemia, but seven ...
Dec 12, 2011 |
not rated yet |
0
B cell receptor inhibitor causes chronic lymphocytic leukemia remission
A new, targeted approach to treating chronic lymphocytic leukemia has produced durable remissions in a Phase I/II clinical trial for patients with relapsed or resistant disease, investigators report at the 53rd Annual Meeting ...
Dec 11, 2011 |
5 / 5 (2) |
0
Genetic evaluation should be part of retinoblastoma care
Results of a study by Baylor College of Medicine physicians underscore the important role that clinical genetic evaluation can have in the management plan of patients with retinoblastoma, a childhood cancer of the eye.
Nov 14, 2011 |
5 / 5 (1) |
0
Age no longer a barrier to stem cell transplantation for older patients
Age alone no longer should be considered a defining factor when determining whether an older patient with blood cancer is a candidate for stem cell transplantation. That's the conclusion of the first study summarizing long-term ...
Nov 01, 2011 |
4 / 5 (1) |
0
|
Bone marrow cells migrate to tumors and can slow their growth
Bone marrow-derived cells (BMDCs) participate in the growth and spread of tumors of the breast, brain, lung, and stomach. To examine the role of BMDCs, researchers developed a mouse model that could be used to track the migration ...
Oct 07, 2011 |
5 / 5 (1) |
0
List of search results for hematological malignancy
